Identification of dipeptidyl peptidase 3 as the Angiotensin-(1–7) degrading peptidase in human HK-2 renal epithelial cells

Peptides

Volumn 83, Issue , 2016, Pages 29-37

  Cruz Diaz, Nildris ^a   Wilson, Bryan A ^a   Pirro, Nancy T ^a   Brosnihan, K Bridget ^a   Marshall, Allyson C ^b   Chappell, Mark C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b TKL RESEARCH INC   (United States)

Author keywords

Angiotensin (1 7); DPP 3; HK 2 cells; Renin angiotensin system

Indexed keywords

ANGIOTENSIN[1-7]; BOVINE SERUM ALBUMIN; DIPEPTIDYL PEPTIDASE; DIPEPTIDYL PEPTIDASE 3; HEAT SHOCK PROTEIN 70; KERATIN; PEPTIDASE; UNCLASSIFIED DRUG; ANGIOTENSIN I; ANGIOTENSIN I (1-7); ANGIOTENSIN II; DPP3 PROTEIN, HUMAN; JMV 390-1; OLIGOPEPTIDE; PEPTIDE FRAGMENT; REACTIVE OXYGEN METABOLITE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME ISOLATION; ENZYME PURIFICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROPHOBIC INTERACTION CHROMATOGRAPHY; IC50; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; ION EXCHANGE; KIDNEY TUBULE CELL; KINETICS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; DRUG EFFECTS; EPITHELIUM CELL; GENETICS; HYDROLYSIS; KIDNEY; METABOLISM;

ANGIOTENSIN I; ANGIOTENSIN II; DIPEPTIDYL-PEPTIDASES AND TRIPEPTIDYL-PEPTIDASES; EPITHELIAL CELLS; HUMANS; HYDROLYSIS; KIDNEY; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; REACTIVE OXYGEN SPECIES;

EID: 84977615286     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2016.06.005     Document Type: Article

References (28)

1. [1] Abramic, M., Schleuder, D., Dolovcak, L., Schroder, W., Strupat, K., Sagi, D., Peter-Katalini, J., Vitale, L., Human and rat dipeptidyl peptidase III: biochemical and mass spectrometric arguments for similarities and differences. Biol. Chem. 381 (2000), 1233–1243.
2. [2] Abramic, M., Simaga, S., Osmak, M., Cicin-Sain, L., Vukelic, B., Vlahovicek, K., Dolovcak, L., Highly reactive cysteine residues are part of the substrate binding site of mammalian dipeptidyl peptidases III. Int. J. Biochem. Cell Biol. 36 (2004), 434–446.
3. [3] Alzayadneh, E.M., Chappell, M.C., Angiotensin-(1–7) abolishes AGE-induced cellular hypertrophy and myofibroblast transformation via inhibition of ERK 1/2. Cell. Signalling 26 (2014), 3027–3036.
4. [4] Chappell, M.C., Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1–7) mas receptor axis; more than regulation of blood pressure?. Hypertension 50 (2007), 596–599.
5. [5] Chappell, M.C., Nonclassical renin-angiotensin system and renal function. Compr. Physiol. 2 (2012), 2733–2752.
6. [6] Chappell, M.C., Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute. Am. J. Physiol. Heart Circ. Physiol. 310 (2016), H137–H152.
7. [7] Chappell, M.C., Brosnihan, K.B., Diz, D.I., Ferrario, C.M., Identification of angiotensin-(1–7) in rat brain: evidence for differential processing of angiotensin peptides. J. Biol. Chem. 264 (1989), 16518–16523.
8. [8] Chappell, M.C., Marshall, A.C., Alzayadneh, E.M., Shaltout, H.A., Diz, D.I., Update on the angiotensin converting enzyme 2-angiotensin (1–7)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways. Front. Endocrinol. (Lausanne) 4 (2014), 201–215.
9. [9] Gallagher, P.E., Arter, A.L., Deng, G., Tallant, E.A., Angiotensin-(1–7): a peptide hormone with anti-cancer activity. Curr. Med. Chem. 21 (2014), 2417–2423.
10. [10] Gallagher, P.E., Tallant, E.A., Inhibition of human lung cancer cell growth by Angiotensin-(1–7). Carcinogenesis 25 (2004), 2045–2052.
11. [11] Krishnan, B., Smith, T.L., Dubey, P., Zapadka, M.E., Torti, F.M., Willingham, M.C., Tallant, E.A., Gallagher, P.E., Angiotensin-(1–7) attenuates metastatic prostate cancer and reduces osteoclastogenesis. Prostate 73 (2013), 71–82.
12. [12] Krishnan, B., Torti, F.M., Gallagher, P.E., Tallant, E.A., Angiotensin-(1–7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1. Prostate 73 (2013), 60–70.
13. [13] Marshall, A.C., Shaltout, H.A., Pirro, N.T., Rose, J.C., Diz, D.I., Chappell, M.C., Antenatal betamethasone exposure is associated with lower ANG-(1–7) and increased ACE in the CSF of adult sheep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 305 (2013), R679–R688.
14. [14] Marshall, A.C., Shaltout, H.A., Pirro, N.T., Rose, J.C., Diz, D.I., Chappell, M.C., Enhanced activity of an angiotensin-(1–7) neuropeptidase in glucocorticoid-induced fetal programming. Peptides 52 (2014), 74–81.
15. [15] Marshall, A.C., Pirro, N.T., Rose, J.C., Diz, D.I., Chappell, M.C., Evidence for an angiotensin-(1–7) neuropeptidase in the brain medulla and CSF of sheep. J. Neurochem. 130 (2014), 313–323.
16. [16] Menon, J., Soto-Pantoja, D.R., Callahan, M.F., Cline, J.M., Ferrario, C.M., Tallant, E.A., Gallagher, P.E., Angiotensin-(1–7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2. Cancer Res. 67 (2007), 2809–2815.
17. [17] Navar, L.G., Kobori, H., Prieto, M.C., Gonzalez-Villalobos, R.A., Intratubular renin-angiotensin system in hypertension. Hypertension 57 (2011), 355–362.
18. [18] Prajapati, S.C., Chauhan, S.S., Dipeptidyl peptidase III: a multifaceted oligopeptide N-end cutter. FEBS J. 278 (2011), 3256–3276.
19. 2+ concentration in human embryonic kidney 293 T cells. Biol. Chem. 397 (2016), 457–462.
20. [20] Santos, R.A., Angiotensin-(1–7). Hypertension, 2014, 631138–631147.
21. [21] Shalamanova, L., Wilkinson, M.C., McArdle, F., Jackson, M.J., Rustom, R., Characterization of the expression of the Renin-Angiotensin system in primary and immortalized human renal proximal tubular cells. Nephron Exp. Nephrol. 116 (2010), e53–e61.
22. [22] Simaga, S., Babic, D., Osmak, M., Ilic-Forko, J., Vitale, L., Milicic, D., Abramic, M., Dipeptidyl peptidase III in malignant and non-malignant gynecological tissue. Eur. J. Cancer 34 (1998), 399–405.
23. [23] Simaga, S., Babic, D., Osmak, M., Sprem, M., Abramic, M., Tumor cytosol dipeptidyl peptidase III activity is increased with histological aggressiveness of ovarian primary carcinomas. Gynecol. Oncol. 91 (2003), 194–200.
24. [24] Soto-Pantoja, D.R., Menon, J., Gallagher, P.E., Tallant, E.A., Angiotensin-(1–7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor. Mol. Cancer Ther. 8 (2009), 1676–1683.
25. [25] Wilson, B.A., Cruz-Diaz, N., Marshall, A.C., Pirro, N.T., Su, Y., Gwathmey, T.M., Rose, J.C., Chappell, M.C., An angiotensin-(1–7) peptidase in the kidney cortex, proximal tubules, and human HK-2 epithelial cells that is distinct from insulin-degrading enzyme. Am. J. Physiol. Renal Physiol. 308 (2015), F594–F601.
26. [26] Wilson, B.A., Marshall, A.C., Alzayadneh, E.M., Chappell, M.C., The ins and outs of angiotensin processing within the kidney. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307 (2014), R487–R489.
27. [27] Wilson, B.A., Nautiyal, M., Gwathmey, T.M., Rose, J.C., Chappell, M.C., Evidence for a mitochondrial angiotensin-(1–7) system in the kidney. Am. J. Physiol. Renal Physiol. 310 (2016), F637–F645.
28. [28] Zhang, K., Meng, X., Li, D., Yang, J., Kong, J., Hao, P., Guo, T., Zhang, M., Zhang, Y., Zhang, C., Angiotensin-(1–7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin i receptor blockade. Kidney Int. 87 (2015), 359–369.